More Starpharma Holdings Limited news
Starpharma Holdings LimitedASX: SPL

Okamoto licenses VivaGel antiviral condom in Asian countries

Mar 3, 2020 at 11:05 PM EST · Issued by Starpharma Holdings Limited

Filed with ASX · Mar 3, 2020 at 11:05 PM EST · 2 pages · English

On 6ix: 6ix.com/news/okamoto-licenses-vivagel-antiviral-condom-in-asian-countries

Starpharma Holdings Limited on 6ix

Story so far

  • VivaGel BV launched in AsiaFeb 13, 2020
  • VivaGel condom receives regulatory approval in EuropeNov 20, 2019
  • UK launch of VivaGel BVNov 13, 2019

Earlier from Starpharma

  • VivaGel BV launched in AsiaFeb 12, 2020
  • Starpharma receives US$3M milestone from AstraZenecaFeb 10, 2020
  • Quarterly Cashflow ReportJan 28, 2020
  • Commencement of phase 1 trial for AZD0466 utilising DEPDec 29, 2019
  • Starpharma receives $4.9M R&D tax incentive refundDec 15, 2019

Later from Starpharma

  • Quarterly Cashflow and Activity ReportApr 7, 2020
  • SPL7013 shows significant activity against coronavirusApr 15, 2020
  • DEP irinotecan phase 2 commences after positive phase 1May 7, 2020
  • VivaGel BV launched in central and eastern EuropeJun 16, 2020
  • DEP lutetium effective in human prostate cancer modelJun 17, 2020
All Starpharma news releases↗

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer